NIKKEI 225
39,135.91 +66.23 (+0.17%) HANG SENG
19,228.41 -407.81 (-2.08%) CRUDE OIL
79.29 -0.51 (-0.64%) GOLD FUTURES
2,413.70 -24.80 (-1.02%) DOW
39,806.77 -196.82 (-0.49%) Bitcoin GBP
56,118.49 +3,618.95 (+6.89%)
SRRK Jul 2024 20.000 call
| Previous close | 2.3900 |
| Open | 2.3900 |
| Bid | 0.7500 |
| Ask | 1.7000 |
| Strike | 20.00 |
| Expiry date | 2024-07-19 |
| Day's range | 2.3900 - 2.3900 |
| Contract range | N/A |
| Volume | |
| Open interest | 14 |
Business WireScholar Rock to Participate in Upcoming Investor Conferences
CAMBRIDGE, Mass., May 20, 2024--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today announced that management will participate in the following upcoming investor conferences in June:
- Business Wire
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., May 17, 2024--Scholar Rock (NASDAQ: SRRK; the "Company"), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy, cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today announced that the company granted inducement equity awards covering an aggregate of 102,150 shares of its common stock to six newly hired employees, consisting of inducement stock options to purchas
Business WireScholar Rock to Host Investor Day on May 22, 2024
CAMBRIDGE, Mass., May 14, 2024--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today announced it will host an Investor Day on Wednesday, May 22, 2024 beginning at 8:30 a.m. ET in New York City.
